Learning Objectives:
Define the key pharmacologic therapies for HFrEH and HFpEF and describe their optimal use in specific patient population
Discuss the barriers and the necessary resources required for successful rapid up-titration of GDMT
Identify how improvement in medical therapy influences patient outcomes, including hospitalizations, re-admissions, and mortality
Speakers:
Biykem Bozkurt, MD, PhD, Professor of Cardiology, Baylor College of Medicine
Selma Mohammed, MBBS, Advanced Heart Failure and Transplant Cardiology, CHI Health
Panelists:
Joseph Rogers, MD, President and Chief Executive Officer, Texas Heart Institute
Jessica Brown, MD, Cardiology and Heart Failure Specialist, Baylor St. Luke's Medical Group Woodlands North Houston Heart Center
Moderator:
Reza Ardehali, MD, Ph.D., FAHA, Professor and Chief of Cardiology, Baylor College of Medicine